Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals's GHG Emissions Data Preview
In 2023, Vertex Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
However, Vertex Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Vertex Pharmaceuticals's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Vertex Pharmaceuticals amounted to 22,075 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Vertex Pharmaceuticals decreased by 3.93%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Vertex Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Vertex Pharmaceuticals's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Vertex Pharmaceuticals were 7,670 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Vertex Pharmaceuticals reduced its Scope 1 emissions over time?
Since 2018, Vertex Pharmaceuticals's Scope 1 emissions have increased by 35.42%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Vertex Pharmaceuticals's Scope 1 emissions decreased by 12.07%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Vertex Pharmaceuticals's Scope 2 emissions?
In 2023, Vertex Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 4,888 tCOâ‚‚e using the market-based method, and 14,405 tCOâ‚‚e using the location-based method.
Has Vertex Pharmaceuticals reduced its Scope 2 emissions over time?
Compared to the previous year (2022), Vertex Pharmaceuticals's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Vertex Pharmaceuticals 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Vertex Pharmaceuticals use for Scope 2 reporting?
In 2023, Vertex Pharmaceuticals reported its Scope 2 emissions using the market-based method and using the location-based method.
Vertex Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Vertex Pharmaceuticals's Value Chain Emissions
In 2023, Vertex Pharmaceuticals reported 474,129 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Vertex Pharmaceuticals includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Vertex Pharmaceuticals's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Vertex Pharmaceuticals's Scope 3 emissions?
In 2023, Vertex Pharmaceuticals reported total Scope 3 emissions of 474,129 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2022), Vertex Pharmaceuticals's Scope 3 emissions increased by 89.79%, suggesting that the company faced challenges in reducing emissions across its value chain.
Insights into Vertex Pharmaceuticals's Total Carbon Footprint
In 2023, Vertex Pharmaceuticals reported a total carbon footprint of 496,204 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 81.9% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Vertex Pharmaceuticals's total carbon footprint was Scope 3 emissions, accounting for 95.55% of the company's total carbon footprint, followed by Scope 2 emissions at 2.9%.